Genetic modulation of oxytocin sensitivity : a pharmacogenetic approach
Genetic modulation of oxytocin sensitivity : a pharmacogenetic approach
Date
2015
Authors
Chen, Frances S.
Kumsta, Robert
Domes, Gregor
Yim, O. S.
Ebstein, Richard P.
Editors
Journal ISSN
Electronic ISSN
ISBN
Bibliographical data
Publisher
Series
URI (citable link)
DOI (citable link)
International patent number
Link to the license
EU project number
Project
Open Access publication
Collections
Title in another language
Publication type
Journal article
Publication status
Published
Published in
Translational Psychiatry ; 5 (2015), 10. - e664. - eISSN 2158-3188
Abstract
Intranasal administration of the neuropeptide oxytocin has been shown to influence a range of complex social cognitions and social behaviors, and it holds therapeutic potential for the treatment of mental disorders characterized by social functioning deficits such as autism, social phobia and borderline personality disorder. However, considerable variability exists in individual responses to oxytocin administration. Here, we undertook a study to investigate the role of genetic variation in sensitivity to exogenous oxytocin using a socioemotional task. In a randomized, double-blind, placebo-controlled experiment with a repeated-measures (crossover) design, we assessed the performance of 203 men on an emotion recognition task under oxytocin and placebo. We took a haplotype-based approach to investigate the association between oxytocin receptor gene variation and oxytocin sensitivity. We identified a six-marker haplotype block spanning the promoter region and intron 3 that was significantly associated with our measure of oxytocin sensitivity. Specifically, the TTCGGG haplotype comprising single-nucleotide polymorphisms rs237917-rs2268498-rs4564970-rs237897-rs2268495-rs53576 is associated with increased emotion recognition performance under oxytocin versus placebo, and the CCGAGA haplotype with the opposite pattern. These results on the genetic modulation of sensitivity to oxytocin document a significant source of individual differences with implications for personalized treatment approaches using oxytocin administration.
Summary in another language
Subject (DDC)
150 Psychology
Keywords
Conference
Review
undefined / . - undefined, undefined. - (undefined; undefined)
Cite This
ISO 690
CHEN, Frances S., Robert KUMSTA, Fabian DVORAK, Gregor DOMES, O. S. YIM, Richard P. EBSTEIN, Markus HEINRICHS, 2015. Genetic modulation of oxytocin sensitivity : a pharmacogenetic approach. In: Translational Psychiatry. 5(10), e664. eISSN 2158-3188. Available under: doi: 10.1038/tp.2015.163BibTex
@article{Chen2015Genet-33432, year={2015}, doi={10.1038/tp.2015.163}, title={Genetic modulation of oxytocin sensitivity : a pharmacogenetic approach}, number={10}, volume={5}, journal={Translational Psychiatry}, author={Chen, Frances S. and Kumsta, Robert and Dvorak, Fabian and Domes, Gregor and Yim, O. S. and Ebstein, Richard P. and Heinrichs, Markus}, note={Article Number: e664} }
RDF
<rdf:RDF xmlns:dcterms="http://purl.org/dc/terms/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:bibo="http://purl.org/ontology/bibo/" xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:void="http://rdfs.org/ns/void#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/33432"> <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/33432/3/Chen_0-319842.pdf"/> <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2016-03-23T13:40:32Z</dc:date> <dcterms:abstract xml:lang="eng">Intranasal administration of the neuropeptide oxytocin has been shown to influence a range of complex social cognitions and social behaviors, and it holds therapeutic potential for the treatment of mental disorders characterized by social functioning deficits such as autism, social phobia and borderline personality disorder. However, considerable variability exists in individual responses to oxytocin administration. Here, we undertook a study to investigate the role of genetic variation in sensitivity to exogenous oxytocin using a socioemotional task. In a randomized, double-blind, placebo-controlled experiment with a repeated-measures (crossover) design, we assessed the performance of 203 men on an emotion recognition task under oxytocin and placebo. We took a haplotype-based approach to investigate the association between oxytocin receptor gene variation and oxytocin sensitivity. We identified a six-marker haplotype block spanning the promoter region and intron 3 that was significantly associated with our measure of oxytocin sensitivity. Specifically, the TTCGGG haplotype comprising single-nucleotide polymorphisms rs237917-rs2268498-rs4564970-rs237897-rs2268495-rs53576 is associated with increased emotion recognition performance under oxytocin versus placebo, and the CCGAGA haplotype with the opposite pattern. These results on the genetic modulation of sensitivity to oxytocin document a significant source of individual differences with implications for personalized treatment approaches using oxytocin administration.</dcterms:abstract> <dc:contributor>Heinrichs, Markus</dc:contributor> <dc:creator>Yim, O. S.</dc:creator> <dc:creator>Domes, Gregor</dc:creator> <dc:contributor>Yim, O. S.</dc:contributor> <dc:creator>Heinrichs, Markus</dc:creator> <dc:contributor>Kumsta, Robert</dc:contributor> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <dc:contributor>Chen, Frances S.</dc:contributor> <dc:contributor>Dvorak, Fabian</dc:contributor> <dcterms:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/"/> <foaf:homepage rdf:resource="http://localhost:8080/"/> <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/33432/3/Chen_0-319842.pdf"/> <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/43"/> <dc:language>eng</dc:language> <dc:creator>Chen, Frances S.</dc:creator> <dc:contributor>Ebstein, Richard P.</dc:contributor> <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2016-03-23T13:40:32Z</dcterms:available> <dc:rights>Attribution 4.0 International</dc:rights> <dc:creator>Ebstein, Richard P.</dc:creator> <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/43"/> <dc:creator>Dvorak, Fabian</dc:creator> <dc:creator>Kumsta, Robert</dc:creator> <dc:contributor>Domes, Gregor</dc:contributor> <dcterms:issued>2015</dcterms:issued> <bibo:uri rdf:resource="https://kops.uni-konstanz.de/handle/123456789/33432"/> <dcterms:title>Genetic modulation of oxytocin sensitivity : a pharmacogenetic approach</dcterms:title> </rdf:Description> </rdf:RDF>